Decades ago, a Company embarked on the journey to understand the twin benefits of a meaningful combination of medicine and nutrition. That Company - Alchem International Ltd which started making a significant impact years ago, has firmly arrived, with an array of nutraceutical products, duly acknowledged and widely accepted.

The processes, intensive research, planned investment, integrated capabilities, value additions through bio-technology, semi-synthesis, foot prints in the formulation space, directional progression and commitment to the cause has given the nutraceutical products of Alchem International Ltd deserved respect by the international community.

The production facilities have USFDA, EU GMP and WHO accreditations. Total commitment to quality drives the Company to its settled goals. Work towards growth resonates through the Company.

Alchem International with 75 years of experience in the phytochemical space has been diligently providing plant derived ingredients, active pharmaceutical ingredients and bulk drugs to all international significant geographies and the Company's interest in skin care is logical to its dimensional growth.

Sheer Quality drives Alchem’s operations

Through perfect blend of science and nature, dedicated research, selection of finest botanical herbal extracts and focused technology, Alchem has successfully extracted the potent active molecules in the plant and offers it for nutraceutical use to help various companies spread wellness.

Valerian Officinalis Extract
"For nutraceutical use, Alchem offers Valerian Officinalis Extract with all its inherent benefits"

Valerian Officinalis Extract is an herbal extract isolated from the root of the plant Valeriana officinalis. It is a perennial flowering plant, with heads of sweetly scented pink or white flowers that bloom in the summer months. Other names used for this plant include garden valerian, garden heliotrope and all-heal. Valeriana officinalis extract contains four distinct classes of phytochemical constituents: volatile oils; sesquiterpenoids, including valerenic acid and its hydroxyl and acetoxyl derivative; valepotriates; and volatile pyridine alkaloids.

The essential oils in valerian appear to provide its sedative activity, while the valepotriates exert a regulatory effect on the autonomic nervous system. Although more than 150 constituents have been identified, none appear to be solely responsible for valerian’s effects, suggesting many compounds may act synergistically. Valerian interacts with neurotransmitters such as GABA and produces a dose-dependent release of GABA. Valerian also inhibits the enzyme-induced breakdown of GABA in the brain, with concomitant sedation. Valerian’s inherent GABA content could directly cause sedation, although concerns exist regarding bioavailability. The valerian lignan hydroxypinoresinol has been found to bind to benzodiazepine receptors. The valepotriates may act as prodrugs through biotransformation into homobaldrinal by bacterial flora. Finally, valerian’s sedative effect acts more as a nervous system depressant than as a muscle relaxant.

Valerian is most often used for the treatment of insomnia and other sleep disorders. It can be considered an alternative treatment for hypnotic drugs. It is also sometimes used as an alternative for sedatives, such as benzodiazepines in the treatment of certain anxiety disorders. In addition, valerian is used to treat gastrointestinal pain caused by irritable bowel syndrome. It has also been used in alternative medicine to treat symptoms such as nervous tension, excitability, stress as well as intestinal colic or cramps and as a muscle relaxant.

The product addresses broad spectrum physiological concerns and has the band width and capabilities to meet expectations. Regular use should exhibit demonstrable results to inhibit various health related issues.